Back Pain Without Radiation Clinical Trial
Official title:
Effect of Duloxetine 60 mg to 120 mg Once Daily in Patients With Chronic Low Back Pain
The primary purpose of your participation in this study is to help answer the following
research question, and not to provide you treatment for your condition.
Whether duloxetine once daily can help patients with Chronic Low Back Pain.
Patients who do not have their pain reduced by at least 30% by week 7 will be given 120 mg
dose for the duration of the study. After the 13 week double blind period, patients
randomized to placebo will switch to duloxetine 60 mg or 120 mg in the 41-week extension
period.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03106740 -
Evaluating the Role of Neuroinflammation in Low Back Pain
|
Phase 2 | |
Withdrawn |
NCT03449160 -
Postural Training Device (UPRIGHT) for Back Pain
|
N/A | |
Completed |
NCT03984903 -
Different Learning Methods of Motor Control Exercises
|
N/A | |
Completed |
NCT03861611 -
A Comparison of NSAIDs for Acute, Non-radicular Low Back Pain.
|
Phase 4 | |
Completed |
NCT04968535 -
Effect of Regular Electrotherapy in Patients With Chronic Non-specific Neck Pain and Low-back Pain
|
N/A | |
Completed |
NCT05585294 -
Water Versus Land Based Perturbation Exercises in Elderly Participants With Back Pain
|
N/A | |
Completed |
NCT00408876 -
Duloxetine Versus Placebo in Chronic Low Back Pain
|
Phase 3 | |
Recruiting |
NCT03912519 -
Parallel Versus Perpendicular Technique for Lumbar Medial Branch Radiofrequency Neurotomy
|
N/A |